Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Leveraging Artificial Intelligence in the Diagnosis of Neurodegenerative Disorders (Alzheimer's and Dementia) and in Managing Medication Schedules"
0
Zitationen
12
Autoren
2025
Jahr
Abstract
The Alzheimer's disease (AD) is recognized as one of the most common neurodegenerative causes of dementia worldwide, having been characterized by progressive cognitive decline for the most part. Early diagnosis is crucial for effective management and intervention. It has been widely recognized recently that deep learning (DL) has been enlightened as a powerful tool to automate the analysis of medical images, especially when it comes to magnetic resonance imaging (MRI), to detect and classify the stages of AD. Consequently, AI-Based Alzheimer’s Diagnostic and Assistance System (AIDAS) leverages artificial intelligence (AI) and deep learning technologies to facilitate the automated identification, classification, and monitoring of AD progression through sophisticated analysis of neuroimaging data. Furthermore, AIDAS integrates intelligent assistance features such as personalized medication reminders and cognitive support tools, thereby enhancing patient adherence, optimizing clinical decision-making, and contributing to a more proactive and precision-driven approach to neurodegenerative disease management. The investigation employed a dataset consisting of 80,000 MRI brain scans acquired along the brain's z-axis, with class labels derived from the Clinical Dementia Rating (CDR) guidelines. This dataset includes 461 people and was derived from the Open Access Series of Imaging Study (OASIS). The experimental results underscore that the proposed ordinal EfficientNetB0 architecture outperforms other models in fundamental structural tasks, characterized by minimal computational overhead, reduced susceptibility to overfitting, efficient memory utilization, and effective temporal regulation. Furthermore, the developed Convolutional Neural Network (CNN) model demonstrated exceptional performance, achieving classification accuracies of 99.5% for AD stage identification.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.260 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.116 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.493 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.438 Zit.